Chiesi Group

    OverviewSuggest Edit

    Chiesi Group is a company that researches, develops, produces, and commercializes therapeutic solutions. It focuses on respiratory, neonatology, rare disease, and special care areas. In addition, the company specializes in drug discovery, preclinical research, manufacturing controls, clinical development, regulatory affairs, pharmacovigilance, etc.
    TypePrivate
    Founded1935
    HQParma, IT
    Websitechiesigroup.com

    Latest Updates

    Employees (est.) (Sept 2021)4,310
    Cybersecurity ratingAMore
    Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
    Banner background

    Chiesi Group Office Locations

    Chiesi Group has an office in Parma
    Parma, IT (HQ)
    Via Palermo, 26A
    Show all (1)

    Chiesi Group Financials and Metrics

    Summary Metrics

    Founding Date

    1935

    Chiesi Group Cybersecurity Score

    Cybersecurity ratingPremium dataset

    A

    93/100

    SecurityScorecard logo

    Chiesi Group Online and Social Media Presence

    Embed Graph

    Chiesi Group News and Updates

    Chiesi Group calls for #ActionOverWords in the fight against climate change

    CARY, N.C., May 10, 2021 (GLOBE NEWSWIRE) -- Chiesi USA (key-ay-zee), the U.S. affiliate of Chiesi Farmaceutici, an international research-focused healthcare Group (Chiesi Group), unveiled its plan to become carbon neutral by 2030 on direct greenhouse gas (GHG) emissions and indirect GHG emissions…

    Chiesi Group receives European Marketing Authorization for Trimbow® inhalation powder (beclometasone dipropionate, formoterol fumarate dihydrate and glycopyrronium) delivered through NEXThaler, an extrafine formulation fixed triple combination therapy for the treatment of moderate to severe COPD

    PARMA, Italy, April 21, 2021 (GLOBE NEWSWIRE) -- Chiesi, an international research-focused healthcare group (Chiesi Group), today announced that the European Commission has granted the marketing authorization for Trimbow® inhalation powder delivered through NEXThaler (beclometasone dipropionate, f…

    Chiesi Group announces performance growth in 2020

    CARY, N.C., March 18, 2021 (GLOBE NEWSWIRE) -- Chiesi USA (key-ay-zee), the U.S. affiliate of Chiesi Farmaceutici, an international research-focused healthcare Group (Chiesi Group), announced performance growth of Chiesi Group in 2020, with a turnover of €2.229 billion and an increase of 11.8% com…

    Chiesi Group receives the European Marketing authorization for the extrafine triple-combination therapy for the treatment of moderate to severe asthma

    PARMA, Italy, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Chiesi, an international research-focused Healthcare group (Chiesi Group), announces that the European Commission has granted the marketing authorization for Chiesi extrafine triple therapy combination ICS/LABA/LAMA in a single inhaler, for the treat…

    Chiesi Group Receives FDA Approval for Ferriprox (deferiprone) twice-a-day tablets

    BOSTON, May 21, 2020 ( ) -- Chiesi Global Rare Diseases, a business unit of Chiesi Farmaceutici S.p.A., an international research-focused healthcare Group (Chiesi Group), today announced that the U.S. Food and Drug Administration (FDA) has approved Ferriprox® (deferiprone) twice-a-day tablets for th…

    Third Pole Therapeutics Announces Global Commercialization Agreement with Chiesi Group for Its Tankless, Portable Inhaled Nitric Oxide (iNO) Delivery System

    WALTHAM, Mass., April 8, 2020 /PRNewswire/ -- Third Pole Therapeutics, a privately held company developing and delivering critical life-sustaining cardio-pulmonary therapies, announced it has entered into a global license, development and commercialization agreement with Chiesi...

    Chiesi Group Frequently Asked Questions

    • When was Chiesi Group founded?

      Chiesi Group was founded in 1935.

    • How many employees does Chiesi Group have?

      Chiesi Group has 4,317 employees.

    • Who are Chiesi Group competitors?

      Competitors of Chiesi Group include Biogen, Livzon Pharmaceutical Group and Cipla.

    • Where is Chiesi Group headquarters?

      Chiesi Group headquarters is located at Via Palermo, 26A, Parma.

    • Where are Chiesi Group offices?

      Chiesi Group has an office in Parma.

    • How many offices does Chiesi Group have?

      Chiesi Group has 1 office.